ARG1 and Stroke: As shown in Figure 3, the expression of M1 markers (TNF-α, IL-12, CD16, CD32 and iNOS) and M2 markers (Arg-1 and YM1/2) were all significantly increased in vehicle-treated stroke mice 3 days after dMCAO.